Annette North - Net Worth and Insider Trading
Annette North Net Worth
The estimated net worth of Annette North is at least $2 Million dollars as of 2024-09-22. Annette North is the EVP & General Counsel of Turning Point Therapeutics Inc and owns about 27,979 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $2 Million. Details can be seen in Annette North's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Annette North has not made any transactions after 2022-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Annette North
Annette North Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Annette North owns 2 companies in total, including Turning Point Therapeutics Inc (TPTX) , and Kura Oncology Inc (KURA) .
Click here to see the complete history of Annette North’s form 4 insider trades.
Insider Ownership Summary of Annette North
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TPTX | Turning Point Therapeutics Inc | 2022-02-09 | EVP & General Counsel & Secty. |
| KURA | Kura Oncology Inc | 2015-03-06 | SVP & General Counsel |
Annette North Latest Holdings Summary
Annette North currently owns a total of 1 stock. Annette North owns 27,979 shares of Turning Point Therapeutics Inc (TPTX) as of February 9, 2022, with a value of $2 Million.
Latest Holdings of Annette North
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TPTX | Turning Point Therapeutics Inc | 2022-02-09 | 27,979 | 76.01 | 2,126,684 |
Holding Weightings of Annette North
Annette North Form 4 Trading Tracker
According to the SEC Form 4 filings, Annette North has made a total of 4 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Turning Point Therapeutics Inc is the sale of 669 shares on February 9, 2022, which brought Annette North around $24,285.
Insider Trading History of Annette North
- 1
Annette North Trading Performance
Annette North Ownership Network
Annette North Owned Company Details
What does Turning Point Therapeutics Inc do?
Who are the key executives at Turning Point Therapeutics Inc?
Annette North is the EVP & General Counsel & Secty. of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .
Turning Point Therapeutics Inc (TPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turning Point Therapeutics Inc Insider Transactions
Annette North Mailing Address
Above is the net worth, insider trading, and ownership report for Annette North. You might contact Annette North via mailing address: C/o Sgx Pharmaceuticals, Inc., 10505 Roselle Street, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
